KenjiIshikura SagamiharaJapan

Time	Session

15:45 16:45	Cutting Edge Science in Nephrotic Syndrome/FSGS KenjiIshikura Moderator Japan Genetics of Nephrotic Syndrome and FSGS DanielGale Speaker d.gale@ucl.ac.ukUnited Kingdom Immunology of Podocyte Injury: Nephrotic Syndrome and FSGS Hans-JoachimAnders Speaker Germany New Translational Insights in B-cell Targeted Therapies in Nephrotic Syndrome/FSGS NicolaTomas Speaker Germany Q&A Session 303

Time	Session

08:10 09:10	Industry Symposium 33 JunOh Moderator Germany Welcome and introduction JunOh Speaker Germany The burden of pediatric chronic kidney disease: Epidemiology, etiology and unmet needs KenjiIshikura Speaker Japan Studying pediatric chronic kidney disease: Challenges in evidence generation and clinical research HughMcCarthy Speaker Australia The long-term consequences of childhood CKD: Growth, cardiovascular risk and adult outcomes JunOh Speaker Germany Summary JunOh Speaker Germany Discussion and Q&A 304
15:50 16:50	ISN-IPNA session KenjiIshikura Moderator Japan RulanParekh Moderator Canada Emerging Treatments for Pediatric Nephrotic Syndrome KoichiNAKANISHI Speaker Japan Therapies for Nephrotic Syndrome: Short‑Term Impact, Long‑Term Promise Identify opportunities to integrate short‑term treatment gains with long‑term management strategies RulanParekh Speaker Canada What Clinicians Should Know About Anti-CD20 Monoclonal Antibodies in Childhood Nephrotic Syndrome Eugene Yu HinChan Speaker genegene.chan@gmail.comHong Kong, China Q&A 304